Cadila Pharmaceuticals Ltd. ,headquartered at Ahmedabad, in the State of Gujarat, is one of the largest private pharmaceutical companies in India, that is serving this nation and other countries through their life saving drugs and formulations.
Over the last six decades, the company has been a prominent active player in Indian pharmaceutical and bio-chemical market and selling and marketing these in over hundred other countries around the world. Focused strongly on Innovation and Research, and strategically aligned with their operational effectiveness the company is present in 40+ therapeutic categories spread across 12 specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals etc.
At Cadila Pharmaceuticals, Research and Development is the primary focus of all its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture or Phytochemistry.
The company has strong presence in the Pan African continent through its formulation manufacturing facility at Addis Ababa in Ethiopia, and in southern part of AFRICA.
Their extensive range of product portfolio containing formulations, that cover every aspect of human life, every single category of diseases. Their portfolio of active formulations contain more than 850 key primary dosage forms representing over 45 therapeutic segments and 12 specialities including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics, immunogicals and oncology.
Some of the well-known brands of them are Acenext, Cadicoff, Exenot, Eplecard, Glista etc.